Palo Alto, United States
Tactogen, a United States-based biopharma startup founded in 2020, is pioneering the development of next-generation MDMA-like medicines aimed at enhancing mental wellness. Emphasizing safety and effectiveness, the company is distinguished by its slogan, "Effective prescription mental wellness. For everyone." Co-founded by former Genentech data science leader Matthew Baggott and deeptech entrepreneur Luke Pustejovsky, Tactogen is dedicated to creating gentler psychedelic compounds that minimize the need for costly clinical oversight.
The company's robust intellectual property portfolio encompasses drug discovery methods, novel molecules, and pharmaceutical preparations. These advancements align with its mission to offer safe take-home prescription empathogens that facilitate psychotherapy and psychological growth.
Tactogen received a seed investment on 01 May 2021, backed by 10x Capital, marking an important step in their journey to transform mental health treatments.
